Guidance changed 1 Jul 2026. UK Kidney Association update: IV calcium evidence downgraded to a suggestion; calcium resonium no longer used.
Severity (UKKA): mild 5.5–5.9, moderate 6.0–6.4, severe ≥6.5 mmol/L.
Exclude a spurious result (haemolysis, delay, drip arm) — but never delay treatment if ECG changes or K⁺ ≥6.5.
Act now
- 1
Step 1 — protect the heart if ECG changes: IV calcium.
- 2
Step 2 — shift K⁺ into cells: insulin-glucose (recommended for severe, suggested for moderate) plus nebulised salbutamol as an adjunct.
- 3
Step 3 — remove K⁺: sodium zirconium cyclosilicate (SZC) for severe; consider for moderate.
- 4
Stop K⁺-containing fluids and culprit drugs.
Assess
- ABCDE. 12-lead ECG urgently for K⁺ ≥6.0 (peaked T, flat P, broad QRS, sine wave, brady/arrhythmia).
- Continuous cardiac monitoring for K⁺ ≥6.5, any ECG changes, or K⁺ 6.0–6.4 in an unwell patient.
- Causes: AKI/CKD, drugs (ACEi/ARB, spironolactone, NSAIDs, trimethoprim, K⁺ supplements, heparin), acidosis, tissue breakdown.
Investigations
- Repeat K⁺ at 1, 2, 4, 6 and 24 hours after treating moderate or severe hyperkalaemia (watch for rebound).
- Capillary glucose after insulin-glucose: 0, 30, 60, 90, 120, 180, 240, 300 and 360 minutes.
- U&E, venous gas (pH, bicarbonate), CK if rhabdomyolysis possible.
Manage
- Treat the cause; review RAAS inhibitors once stable rather than stopping long term without a plan.
- IV sodium bicarbonate is not routinely suggested; calcium resonium no longer recommended in the acute setting.
Escalate when
- Severe hyperkalaemia: urgent renal or critical care opinion (critical care first if no on-site renal service).
- Haemodialysis patients with severe hyperkalaemia need urgent dialysis.
- ABC or consciousness problems: critical care.
Doses and prescribing
IV calcium (6.8 mmol): 30 mL 10% calcium gluconate over 10 minutes, or 10 mL 10% calcium chloride over 5 minutes (chloride preferred in cardiac arrest/peri-arrest). Repeat if ECG changes persist. Caution with digoxin.
Insulin-glucose: 10 units soluble insulin with 25 g glucose IV over 15 minutes (e.g. 50 mL 50% or 125 mL 20% — use local preparation).
If pre-treatment glucose <7.0 mmol/L: follow with 10% glucose at 50 mL/h for 5 hours (25 g).
Salbutamol
10–20 mg nebulised — adjunct only, never monotherapy for severe hyperkalaemia.
SZC
10 g three times daily for up to 72 hours. Patiromer 8.4 g is an alternative for K⁺ ≥6.0 (not available in Scotland per UKKA).
Check the BNF and your local formulary before prescribing.
Written to current guidance · sources checked 14 Nov 2026. We watch NICE for updates weekly.
Sources (2)
- UK Kidney Association — Management of hyperkalaemia in adults (updated July 2026)Version 1 Jul 2026, checked 14 Nov 2026
- BNF — check doses, cautions and renal adjustmentchecked 14 Nov 2026
Reviewed by Aboodee Alhasso, MPharm MRCPharm IP on 14 Nov 2026
For healthcare professionals, as an aid to clinical judgement — not a substitute for it. Follow your local policy and ask a senior when in doubt.